We are live on ! Find out more
MMPI

Morgenthaler Management Partners IX Portfolio holdings

AUM $22.6M
This Fund
S&P 500
This Quarter Est. Return
+17.05%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.6M
AUM Growth
-$24.3M
Cap. Flow
-$27.5M
Cap. Flow %
-121.88%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAPO
1
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$22.6M 100%
122,836
RARX
2
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-1,229,782
Closed -$27.5M

Similar funds

Morgenthaler Management Partners IX's Q2 2019 Portfolio in Review

As of Q2 2019, Morgenthaler Management Partners IX held 2 positions worth $22.6M, down 52% from $46.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Morgenthaler Management Partners IX withdrew a net $27.5M in Q2 2019, closing 1 position. Its most notable exit was Ra Pharmaceuticals, Inc. Common Stock, an estimated $27.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Morgenthaler Management Partners IX fully exited Ra Pharmaceuticals, Inc. Common Stock in Q2 2019, selling an estimated $27.5M.
  • Morgenthaler Management Partners IX's ten largest holdings make up 100% of its $22.6M portfolio in Q2 2019.
  • Morgenthaler Management Partners IX opened 0 new positions and closed 1 in Q2 2019.
  • Morgenthaler Management Partners IX's portfolio value fell 52% quarter-over-quarter to $22.6M.

Based on Morgenthaler Management Partners IX's 13F filing for Q2 2019, filed 14 Aug 2019.